Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2016

Study Completion Date

May 31, 2018

Conditions
Non-small Cell Lung Cancer Metastatic
Interventions
DRUG

Vinorelbine

Trial Locations (8)

30035

U.O. Oncologia ed Ematologia Oncologica ULSS 13 MIRANO, Mirano

32100

U.O. Oncologia Medica ULSS 1 Belluno, Belluno

47014

Irccs Irst, Meldola (FC)

47841

U.O. Oncologia Ospedale Cervesi, Cattolica

48018

U.O. Oncologia Ospedale Civile degli Infermi, Faenza

48022

U.O. Oncologia Ospedale Civile Umberto I, Lugo

48121

UO Oncologia Medica, Ospedale S.Maria delle Croci, Ravenna

Unknown

U.O. Oncologia Ospedale degli Infermi, Rimini

All Listed Sponsors
lead

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

OTHER

NCT01848613 - Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC | Biotech Hunter | Biotech Hunter